Kaposi sarcoma-associated herpesvirus/human herpesvirus 8, cytokines, growth factors and HIV in pathogenesis of Kaposi's sarcoma

Current Opinion in Infectious Diseases

Volumn 11, Issue 2, 1998, Pages 97-105

  Biberfeld, Peter ^a   Ensoli, Barbara ^b   Stürzl, Michael ^c   Schulz, Thomas F ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR;

ARTICLE; CELL TYPE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; KAPOSI SARCOMA; LATENT PERIOD; PATHOGENESIS; SPINDLE CELL; VIRUS GENE; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0031978580     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199804000-00002     Document Type: Article

References (109)

1. Boshoff C, Weiss RA. Kaposi's sarcoma-associated herpesvirus. Curr Opin Infect Dis 1997; 10:26-23.
2. Krown SE, Testa MA, Huang J. AIDS related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trial Group Oncology Committee. J Clin Oncol 1997; 15:3085-3092.
3. Ensoli B, Gallo RC. AIDS-associated Kaposi's sarcoma: a new perspective of its pathogenesis and treatment. Proc Ass Am Physicians 1995; 107:8-18.
4. Beral V, Bull D, Darby S, Weller I, Carne C, Beecham M, Jaffe H. Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS. Lancet 1992; 339:632.
5. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865-1869.
6. Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nature Med 1995; 1:707-708.
7. Boshoff C, Moore PS. Kaposi's sarcoma-associated herpesvirus: a newly recognized pathogen. AIDS Clin Rev 1998 (in press).
8. Lin SF, Sun R,Heston L, Gradoville L, Shedd D, Haglund K, Rigsby M, Miller G. Identification, expression end immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen. J Virol 1997; 71:3069-3076.
9. Gao SJ, Kinley L, Li M, Zheng W, Parravicini C, Ziegler J et al. Seroprevalence of KSHV antibodies among North Americans, Italians, and Ugandans with and without Kaposi's sarcoma. Nature Med 1996; 2:925-928.
10. Gao SJ, Kingsley L, Hoover DR, Spira TJ, Rinaldo CR, Saah A et al. Seroconversion of antibodies to Kaposi's sarcoma-associated herpes-virus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996; 335:233-241.
11. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroprevalence of human herpesvirus 8 (HHV 8): distribution of infection in Kaposi's sarcoma risk groups and evidence for sexual transmission. Nature Med 1996; 2:918-924.
12. Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L et al. Prevalence of Kaposi's sarcoma-associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 348:1133-1138.
13. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996; 348:858-861.
14. Calabró ML, Sheldon J, Favero A, Simpson GR, Fiore JR, Gomes E et al. Seroprevalence of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) in different regions of Italy. J Human Virol 1998; (in press).
15. Whitby D, Luppi M, Barozzi P, Boshoff Q, Weiss RA, Torelli G. Human herpesvirus 8 seroprevalence in blood donors and patients with lymphoma from different regions of Italy. J Natl Cancer Inst 1998 (in press).
16. Rainbow L, Platt GM, Simpson GR, Sand R, Gao SJ, Stoiber H et al. The 222-234 kD nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8) is encoded by orf73 and a component of the latency-associated nuclear antigen. J Virol 1997; 71:5915-5921. This study presents the identification of the latent nuclear antigen and a demonstration of its expression in KS tumour cells.
17. Kellam P, Boshoff C, Whitby D, Matthews S, Weiss RA, Talbot SJ. Identification of a major latent nuclear antigen (LNA-1) in the human herpesvirus-8 genome. J Human Virol 1997; 1:19-29.
18. Miller G, Rigsby MO, Heston L, Grogan E, Sun R, Metroka C et al. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIVA infection. N Engl J Med 1996; 334:1292-1297.
19. Andre S, Schatz O, Bogner JR, Zeichhardt H, Stöffler-Meilicke M, Jahn HU et al. Detection of antibodies against viral capsid proteins of human herpesvirus 8 in AIDS-associated Kaposi's sarcoma. J Mol Med Immunol 1997; 75:145-152.
20. Davis DA, Humphrey RW, Newcomb FM, O'Brien TR, Goedert JJ, Straus SE, Yarchoan R. Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide. J Infect Dis 1997; 175:1071-1079.
21. Ablashi DV, Chatlynne LG, Lapps W, Hoekzerna DT, Masood R, Kramarsky B et al. Epidemiology and characterisation of HHV8 from KS-1 cell lines. J Acquir Immune Defic Syndr Human Retrovirol 1997; 14:A23.
22. Smith MS, Bloomer C Horvat R, Goldstein E, Casparian JM, Chandran B. Detection of human herpesvirus 8 DNA in Kaposi's sarcoma lesions and peripheral blood of human immunodeficiency virus-positive patients and correlation with serologic measurements. J Infect Dis 1997; 176:84-93.
23. Monini P, de Lellis L, Fabris M, Rigolin F, Cassai E. Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen. N Engt J Med 1996; 334:1168-1172.
24. Viviano E, Vitale F, Ajello F, Perna AM, Villafrate MR, Bonura F et al. Human herpesvirus type 8 DNA sequences in biological samples of HIV-positive and negative individuals in Sicily. AIDS 1997; 11:607-612.
25. Bigoni B, Dolcetti R, de Lellis L, Carbone A, Boiocchi M, Cassai E, Di-Luca D. Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. J Infect Dis 1996; 173:542-549.
26. Kasolo FC, Mpabalwani E, Gompels UA. Infection with AIDS-related herpesviruses in human immunodeficiency virus-negative infants and endemic childhood Kaposi's sarcoma in Africa. J Gen Virol 1997; 78:847-855.
27. Ariyoshi K, Van der Loeff MS, Corrah T, Cham F, Cook PM, Whitby D et al. Kaposi's sarcoma and human herpesvirus 8 (HHV8) in HIV-1 and HIV-2 infection in The Gambia. J Human Virol 1998 (in press). This study presents epidemiological evidence that infection with HIV-1 may represent a co-factor - for KS development.
28. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C et al. Detection of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood of HIV-infected individuals predicts progression to Kaposi's sarcoma. Lancet 1995; 346:799-802.
29. Howard MR, Whitby D, Bahadur G, Suggett F, Boshoff C, Tenant FM et al. Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors. AIDS 1997; 11:F15-F19.
30. Humphrey RW, O'Brien TR, Newcomb FM, Nishihara H, Wyvill KM, Ramos GA et al. Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugs. Blood 1996; 88:297-301.
31. Gupta P, Singh MK, Rinaldo C, Ding M, Farzadegan H, Saah A et al. Detection of Kaposi's sarcoma herpesvirus DNA in semen of homosexual men with Kaposi's sarcoma. AIDS 1996; 101596-1598.
32. Lebbe C, Pellet C, Tatoud R, Agbalika F, Dosquet P, Desgrez JP et al. Absence of human herpesvirus 8 sequences in prostate specimens. AIDS 1997; 11:270.
33. Neipel F, Albrecht JC, Fleckenstein B. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity. J Virol 1997; 71:4187-4192. This paper reports on the second (nearly) complete sequence of KSHV and an overview over 'pirated' genes with homologies to cellular proteins.
34. Diamond Q Huang ML, Kedes DH, Speck C, Rankin GW Jr, Ganem D et al. Absence of detectable human herpesvirus 8 in the semen of human immunodeficiency virus-infected men without Kaposi's sarcoma. J Infect Dis 1997; 176:775-777.
35. Boldogh I, Szaniszlo P, Bresnahan WA, Flaitz CM, Nichols MC, Albrecht T. Kaposi's sarcoma herpesvirus-like DNA sequences in the saliva of individuals infected with human immunodeficiency virus. Clin Infect Dis 1996; 23:406-407.
36. Vieira JD, Hunag IL, Koelle DM, Corey L. Transmissible Kaposi's-associated Herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma. J Virol 1997; 71:7083-7087.
37. Koelle DM, Huang M-L, Chandran B, Vieira J, Piepkorn M, Corey L. Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates. J Infect Dis 1997; 176:94-102.
38. IARC Monographs on the evaluation of carcinogenic risks to humans. Vol 67: Human immunodeficiency viruses. IARC Press; 1996.
39. Russo JJ, Bohenzky RA, Chen MC, Chen J, Yan M, Maddalena D et al. Nucleotide sequence of Kaposi's sarcoma associated herpesvirus (HHV-8). Proc Natl Acad Sci U S A 1996; 93:14862-14867. This paper reports on the first complete sequence of a KSHV isolate and an overview of the biological activities of encoded genes.
40. Neipel F, Albrecht JC, Ensser A, Huang Y-Q, Li JJ, Friedman-Kien AE, Fleckenstein B. Primary structure of the Kaposi's sarcoma-associated human herpesvirus 8. Genbank accession no. U93872; 1997.
41. Nicholas J, Ruvolo V, Zong J, Ciufo D, Guo HG, Reitz MS, Hayward GS. A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins. J Virol 1997; 71:1963-1974. This study reports on a sequence of a region in the KSHV genome which is not conserved among other gamma herpesviruses and contains many interesting KSHV genes.
42. Nicholas J, Ruvolo VR, Burns WH, Sandford G, Wan X, Ciufo D et al. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nature Med 1997; 3:287-292. See annotation to reference 41 above.
43. Lagunoff D, Ganem D. The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). Virology 1997; 236:147-154.
44. Neipel F, Albrecht JC, Ensser A, Huang YQ, Li JJ, Friedman-Kien AE, Fleckenstein B. Human herpesvirus 8 encodes a homolog of interleukin 6. J Virol 1997; 71:839-842.
45. Guo HG, Browning P, Nicholas J, Hayward GS, Tschachler E, Jiang YW et al. Characterisation of a chemokine receptor-related gene in human herpesvirus 8 and its expression in Kaposi's sarcoma. Virology 1997; 228:371-378.
46. Zong JC, Metroka C, Reitz MS, Nicholas J, Hayward GS. Strain variability among Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genomes: evidence that a large cohort of United States AIDS patients may have been infected by a single common isolate. J Virol 1997; 71:2505-2511.
47. Nicholas J, Zong J, Alcendor DJ, Ciufo D, Poole LJ, Sarisky RT et al. Novel organizational features captured cellular genes and strain variability within the genome of KSHV/HHV8. J Natl Cancer Inst 1998 (in press).
48. Luppi M, Barozzi P, Marasca R, Ferrari MG, Torelli G. Human herpesvirus 8 strain variability in clinical conditions other than Kaposi's sarcoma. J Virol 1997; 71:8082-8083.
49. Boshoff C, Schuiz TF, Kennedy MM, Graham AK, Fisher C, Thomas A et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nature Med 1995; 12:1274-1278.
50. Zhong W, Ganem D. Characterization of ribonucleoprotein complexes containing an abundant polyadenylated nuclear RNA encoded by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). J Virol 1997; 71:1207-1212. Demonstrates the function of a polyadenylated but untranslated nuclear RNA and its possible role in splicing.
51. Staskus KA, Zhong W, Gebhard K, Hemdier B, Wang H, Renne R et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 1997; 71:715-719. This is the first paper to define latently and lytically infected cells in KS tissue by in-situ hybridization.
52. Stürzl M, Blasig C, Schreier A, Neipel F, Hohenadl C, Cornali E et al. Expression of HHV-8 latency-associated TO.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma (KS). Int J Cancer 1997; 72:68-71. This study reports on in-situ hybridization, indicating predominantly latent KSHV/HHV8 infection of KS cells.
53. Li JJ, Huang YQ, Cockerell CJ, Friedman-Kien AE. Localization of human herpes-like virus type 8 in vascular endothelial cells and perivascular spindle-shaped cells of Kaposi's sarcoma lesions by insitu hybridization. Am J Pathol 1996; 148:1741-1748.
54. Blasig C, Zietz Q, Haar B, Neipel F, Esser S, Brockmeyer NH et al. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus-8. J Virol 1997; 10:7963-7968. A demonstration of lytic infection in monocytes and recruitment into KS lesions.
55. Huang YQ, Li JJ, Zhang WG, Feiner D, Friedman-Kien AE. Transcription of human herpesvirus-like agent (HHV-8) in Kaposi's sarcoma. J Clin Invest 1996; 97:2803-2806.
56. Orenstein JM, Alkan S, Blauvett A, Jeang K-T, Weinstein MD, Ganern D, Herndier B. Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy. AIDS 1997; 11:F35-745. A demonstration of lytic infection in a subpopulation of spindle cells, makes the point that KSHV/HHV8 is not strictly latent in KS spindle cells.
57. Sarid R, Flore O, Bohenzky RA, Chang Y, Moore PS. Transcriptional mapping of the Kaposi's sarcoma-associated herpesvirus (KSHV) genome in the body cavity-based lymphoma cell line BC-1. J Virol 1998; 27:1005-1012.
58. Chang Y, Moore PS, Talbot SJ, Boshoff CH, Zarkowska T, Godden-Kent D et al. Cyclin encoded by KS herpesvirus. Nature 1996; 382:410. The authors show that v-cyclin D can abrogate retinoblasma protein-induced inhibition of cell cycle progression.
59. Cheng EH, Nicholas J, Bellows DS, Hayward GS, Guo HG, Reitz MS, Hardwick JM. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci USA 1997; 94:690-694.
60. Li MT, Lee HR, Yoon DW, Albrecht JC, Fleckenstein B, Neipel F, Jung JU. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J Virol 1997; 71:1984-1991. A description of the functional properties of the viral cyclin homologue.
61. Godden-Kent D, Talbot SJ, Boshoff C, Chang Y, Moore P, Weiss RA, Mittnacht S. The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J Virol 1997; 71:4193-4198.
62. Swanton C, Mann DJ, Fleckenstein B, Neipel F, Peters G, Jones N. Herpes viral cyclin/cdk6 complexes evade inhibition by WK inhibitor proteins. Nature 1997; 390:184-187. A detailed description of the mode of action, and lack of inhibition, of the viral cyclin homologue.
63. Thome M, Schneider P, Hofrnan K, Fickenscher H, Meinl E, Neipel F et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997; 386:517-521. The first description of viral FLICE-inhibitory protein homologues.
64. Bertin J, Armstrong RC, Ottilie S, Martins DA, Wang Y, Banks S et al. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc Natl Acad Sci USA 1997; 94:1172-1176.
65. Zhong W, Wang H, Herndier B, Ganem D. Restricted expression of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi's sarcoma. Proc Natl Acad Sci USA 1996; 93: 6641-6646.
66. Bais C, Santomasso B, Coso O, Arvanitakis L, Reaka EG, Gutkind JS et al. G-protein coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 1998; 341:86-89.
67. Kledal TN, Rosenklide MM, Coulin F, Simmons G, Johnsen AH, Alouani S et al. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcomaassociated herpesvirus. Science 1997; 277:1656-1659.
68. Boshoff C, Endo Y, Collins PD, Takeuchi Y, Reeves JD, Schweickart VL et al. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 1997; 278:290-294.
69. Sand R, Sato T, Bohenzky RA, Russo JJ, Chang Y. Kaposi's sarcoma- associated herpesvirus encodes a functional Bcl-2 homologue. Nature Med 1997; 3:293-298. This study presents the functional characterization of the viral bcl-2 homologue.
70. Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996; 274:1739-1744. A description of viral chemokines and ARF.
71. Arvanitakis L, Geras RE, Varma A, Gershengorn MC, Cesarman E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 1997; 385:347-350. A description of the functional properties of the chemokine receptor homologue in KSHV/HHV8.
72. Molden J, Chang Y, You Y, Moore PS, Goldsmith MA. A Kaposi's sarcomaassociated herpesvirus-encoded cytokine homolog (vl-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem 1997; 272:19625-19631. A description of signalling pathways and receptors used by the viral IL6 homologue.
73. Cesarman E, Nador RG, Bai F, Bohenzky RA, Russo JJ, Moore PS et al. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol 1996; 70:8218-8223.
74. Gao SJ, Boshoff C, Jayachandra S, Weiss RA, Chang Y, Moore PS. KSHV orf K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 1997; 15:1979-1985.
75. Davis MA, Stürzl M, Blasig C, Schreier A, Guo HG, Reitz M et al. Human herpesvirus 8 (HHV-8) encodes a homologue of cellular cyclin D2 that is expressed in Kaposi's sarcoma (KS) lesions. J Natl Cancer Inst 1997; 89:1868-1874. In this study v-cyclin D was identified as one of the few genes of HHV-8, which is expressed by latently infected KS spindle cells in KS lesions. As a result of its biological activity v-cyclin D is a very likely candidate to regulate the progression of late-stage KS lesions.
76. Sun R, Lin S-F, Gradoville L, Miller G. Polyadenylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci USA 1996; 93:11883-11888.
77. Murakamimori K, Mori S. Taga T, Kishimoto T, Nakamura S. Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's-sarcoma cells-selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation. J Immunol 1997; 158:5518-5526.
78. Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, Raffeld M et al. Synergy between basic fibroblast growth factor and human immunodeficiency virus type 1 Tat protein in induction of Kaposi's sarcoma. Nature 1994; 371:674-680.
79. Samaniego F, Markham PD, Gendelman R, Gallo RC, Ensoli B. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice. J Immunol 1997; 158:1887-1894.
80. Fiorelli V, Gendelman R, Samaniego F, Markham PD, Ensoli B. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J Clin Invest 1995; 95:1723-1734.
81. +r cells and macrophages, and correlation with the presence of KSHV/HHV8 DNA.
82. Sirianni MC, Vincenzi L, Fiorelli V, Topino S, Scala E, Uccini S et al. gamma;-interferon production in peripheral blood mononuclear cells (PBMC) and tumour infiltrating lymphocytes from Kaposi's sarcoma patients: correlation with the presence of human herpesvirus-8 in PBMC and lesional macrophages. Blood 1998 (in press). A demonstration of CD8 T-cell activation in KS patients and the persistence of KHSV/HHV8 infection in macrophages cultured from KS lesions.
83. Faris M, Ensoli B, Kokot N, Nel AE. Inflammatory cytokines induce the expression of bFGF isoforms required for growth of Kaposi's sarcoma and endothelial cells through the activation of AP-1 response elements of the bFGF promoter. AIDS 1998; 12:19-27.
84. Faris M, Ensoli B, Stahl N, Yancopoulos G, Nguyen A, Wang S, Nel AE. Differential activation of the ERK, Jun Kinase and Janus Kinase-STAT pathways by oncostatin M and basic fibroblast growth factor in AIDS-derived Kaposi's sarcoma cells. AIDS 1996; 10:369-378.
85. Flamand L, Zeman RA, Bryant JL, Lunardi-Iskandar Y, Gallo RC. Absence of human herpesvirus 8 DNA sequences in neoplastic Kaposi's sarcoma cell lines. J Acquir Immune Defic Syndr Human Retrovirol 1996; 13:194-197.
86. Sirianni MC, Uccini S, Angeloni A, Faggioni A, Cottoni F, Ensoli B. Circulating spindle cells: correlation with human herpesvirus-8 (HHV-8) infection and Kaposi's sarcoma. Lancet 1997; 349:255. A demonstration in KS patients of increased levels of circulating spindle cell precursors infected by KSHV/HHV8
87. Cornali E, Zietz C, Benelli R, Weninger W, Masiello L, Breier G et al. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am J Pathol 1996; 149:1851-1869. A demonstration of VEGF in KS and synergy with bFGF in KS development.
88. Samaniego F, Markham PD, Gendelman R, Watanabe Y, Kao V, Kowalski K et al. Vascular endothelial growth factor and basic fibroblast growth factor are expressed in Kaposi's sarcoma and synergize to induce angiogenesis, vascular permeability and KS lesion development: induction by inflammatory cytokines. Am J Pathol 1998 (in press). A demonstration of VEGF in KS and synergy with bFGF in KS development.
89. Zietz C, Hotz B, Stürzl M, Rauch E, Penning P, Löhrs U. Aortic endothelium in HIV-1 infection: chronic injury, activation and increased leukocyte adherence. Am J Pathol 1996; 149:1887-1898. In this study it is shown that the endothelium of HIV-infected patients in vivo is highly activated, reveals dramatic morphological alterations and increased the adhesion of monocytes.
90. Chang HQ, Samaniego F, Nair BC, Buonaguro L, Ensoli B. HIV-1 Tat protein exits from intact cells via a leaderless secretory pathway and binds extracellular matrix-associated heparan sulphate proteoglycans through its basic region. AIDS 1997; 11:1421-1431.
91. Barillari G, Fiorelli V, Gendelman R, Colombini S, Samaniego F, Morris BC et al. HIV-1 Tat protein enhances angiogenesis and Kaposi's sarcoma (KS) development triggered by inflammatory cytokines (IC) or bFGF by engaging the v3 integrin. J Acquir Immune Defic Syndr Human Retrovirol 1997; 114:A33.
92. Albini A, Soldi R, Giunciuglio D, Giraudo E, Benelli R, Primo L et al. The angiogenesis induced by HIVA Tat protein is mediated by the Flk/1/KDR receptor on vascular endothelial cells. Nature Med 1996; 2:1371-1375.
93. Lafrenie RM, Wahl LM, Epstein JS, Hewlett IK, Yarnada KM, Dhawan S. HIV-1 Tat protein promotes chemotaxis and invasive behavior by monocytes. J Immunol 1996; 157: 974-977.
94. Harrington W, Sieczkowski L, Sosa C, Chan-a-Sue S, Cai JP, Cabrai L, Wood C. Activation of HHV-8 by HIV-1 Tat. Lancet 1997; 349:774. PBMC from various patients with or without AIDS, KS and cell lines were cultured with and without recombinant Tat and examined by PCR for HHV8 expression.
95. Morris CB, Gendelman R, Marrogi AJ, Lu M, Lockyer JM, Alpenn-Lea W, Ensoli B. Immunohistochemical detection of bcl-2 in AIDS-associated and classical Kaposi's sarcoma. Am J Pathol 1996; 148:1055-1063. A demonstration of the increasing bcl-2 expression in lesional spindle cells and vessels, according to lesion stage.
96. Rabkin CS, Janz S, Lash A, Coleman AE, Musaba E, Liotta L et al. Monoclonal origin of multicentric Kaposi's sarcoma lesions. New Engl J Med 1997; 336:988-993.
97. Gill P, Tsai Y, Rao AP, Jones P. Clonality in Kaposi's sarcoma. New Engl J Med 1997; 337:570-571.
98. Delabesse E, Oksenhendler E, Lebbe C, Verola O, Varet B, Turhan AG. Molecular analysis of clonality in Kaposi's sarcoma. J Clin Pathol 1997; 50:664-668.
99. Medveczky MM, Horvath E, Lund T, Medveczky PG. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus. AIDS 1997; 11:1327-1332.
100. Kedes DM, Ganem D. Sensitivity of Kaposi's sarcoma associated herpesvirus replivation to antiviral drugs. Implications for potential therapy. J Clin Invest 1997; 99:2083-2086.
101. Jones JL, Hanson DL, Chu SY, Ward JW, Jaffe HW. AIDS-associated Kaposi's sarcoma. Science 1995; 267:1078-1079.
102. Glesby MJ, Hoover DR, Weng S, Graham NM, Phair JP, Detels R, Ho M, Saah AJ. Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study. J Infect Dis 1996; 173:1477-1480.
103. Mocroft A, Youle M, Gazzard B, Morcinek J, Halai R, Phillips AN. Antiherpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. AIDS 1996; 10:1101-1105.
104. Conant MA, Opp KM, Poretz D, Mills RG. Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonovir. AIDS 1997; 11:1300-1301.
105. Blum L, Pellet C, Agbalika F, Blanchard G, Morel P, Calvo F, Lebbé C. Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy. AIDS 1997; 11:1653-1655. A recent report on the regression of adult KS by antiviral therapy.
106. Murphy M, Armstrong D, Sepkowitz KA, Ahkami RN, Myskowski PL. Regression of AIDS-related Kaposi's sarcoma following treatment with HIV-protease inhibitor. AIDS 1997; 11:261-262.
107. Aebischer MC, Zala LB, Braathen LR. Kaposi's sarcoma as manifestation of immunosuppression in organ transplant recipients. Dermatology 1997; 195:91-92.
108. Gill PS, McLaughlin T, Espina BM, Tulpule A, Louie S, Lunardi-Iskander Y, Gallo RC. Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma. J Natl Cancer Inst 1997; 89:1797-1802.
109. Lang ME, Lottersberger C, Roth B, Bock G, Recheis H, Sgonc R et al. Induction of apoptosis in Kaposi's sarcoma spindle cell cultures by the subunits of human chorionic gonadotropin. AIDS 1997; 11:1333-1340.